AdaaniFrostMD

Pleural Disease

Professor, Pulmonology, Baylor College of Medicine

Dr. Frost is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6550 Fannin St
Suite 1101
Houston, TX 77030
Phone+1 713-441-0006

Fax+1 713-790-2727

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Super Doctor SuperDoctors.com

PubMed

99 citations
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
Christopher J. Rhodes, Ken Batai, Marta Bleda, Matthias Haimel, Laura Southgate
The Lancet. Respiratory Medicine. 2019-03-01
718 citations
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Nazzareno Galiè, Joan Albert Barberà, Adaani E. Frost, Hossein Ardeschir Ghofrani, Marius M. Hoeper
The New England Journal of Medicine. 2015-08-26
711 citations
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
David B. Badesch, Victor F. Tapson, Michael D. McGoon, Bruce H. Brundage, Lewis J. Rubin
Annals of Internal Medicine. 2000-03-21

Lectures

10th International Pulmonary Hypertension Conference and Scientific Sessions
Pulmonary Hypertension Association, Orlando, Florida - 6/22/2012

Her Deadly Diagnosis Made Pregnancy Risky. But This Houston Woman Took the LeapOctober 20th, 2022